| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 65 | 92 | 92 | 93 | 114 | 123 | 143 | 144 | 132 | 148 | 155 | 186 | 155 | 174 | 170 | 226 | 178 | 255 | 277 | 314 | 223 |
| Expenses | 52 | 69 | 70 | 70 | 91 | 95 | 111 | 118 | 108 | 119 | 122 | 146 | 120 | 179 | 140 | 182 | 147 | 198 | 206 | 224 | 156 |
| EBITDA | 14 | 23 | 22 | 23 | 23 | 28 | 31 | 26 | 24 | 29 | 34 | 41 | 35 | -5 | 30 | 44 | 31 | 57 | 70 | 91 | 67 |
| Operating Profit % | 20 % | 24 % | 24 % | 25 % | 20 % | 22 % | 21 % | 18 % | 18 % | 19 % | 20 % | 22 % | 22 % | -4 % | 16 % | 19 % | 17 % | 20 % | 25 % | 28 % | 25 % |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 6 | 7 | 6 | 7 | 8 |
| Interest | 1 | 1 | 2 | 1 | 3 | 3 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 3 | 2 | 4 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 11 | 0 | 19 | 21 | 18 | 23 | 29 | 22 | 20 | 26 | 30 | 37 | 31 | -10 | 24 | 37 | 20 | 50 | 63 | 83 | 58 |
| Tax | 3 | -15 | 5 | 5 | 4 | 5 | 9 | 1 | 6 | 7 | 7 | 10 | 9 | 7 | 6 | 12 | 5 | 13 | 18 | 20 | 14 |
| Net Profit | 9 | 15 | 15 | 15 | 14 | 18 | 20 | 21 | 15 | 19 | 22 | 27 | 22 | -17 | 18 | 26 | 15 | 38 | 46 | 63 | 44 |
| EPS in ₹ | 8.49 | 4.83 | 4.59 | 4.89 | 4.36 | 5.11 | 5.69 | 6.22 | 4.08 | 5.50 | 6.28 | 7.47 | 4.57 | -4.67 | 4.83 | 6.85 | 3.67 | 9.38 | 11.35 | 7.80 | 5.41 |
Acutaas Chemicals
Acutaas Chemicals
1,358.10
-53.00
(-3.76%)
Market Cap
11,118.60 Cr
EPS
19.91
PE Ratio
58.90
Dividend Yield
0.11 %
Industry
Healthcare52 Week High
1,530.30
52 Week Low
726.63
PB Ratio
8.50
Debt to Equity
0.12
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from6 analysts
Company News
View All News
ACUTAAS Chemicals Limited shareholders approved the re-appointment of key leadership positions at their Annual General Meeting held on September 25, 2025. Nareshkumar Ramjibhai Patel was re-appointed as Managing Director and Executive Chairman for five years from May 1, 2026 to April 30, 2031. Chetankumar Chhaganlal Vaghasia and Virendra Nath Mishra were re-appointed as Whole Time Directors for five-year terms starting May 1, 2026 and April 1, 2026 respectively. Two independent directors, Richa Manoj Goyal and Hetal Madhukant Gandhi, were also re-appointed for second terms of five consecutive years. Additionally, shareholders approved the appointment of M/s. KSPS & Co. LLP as Secretarial Auditors for a five-year term from FY 2025-26 to FY 2029-30.
Acutaas Chemicals Receives Platinum Medal from EcoVadis, Ranking in Top 1% Globally for Sustainability
Aug 27, 2025
Aug 27, 2025Acutaas Chemicals Limited received a Platinum Medal accreditation from EcoVadis based on their sustainability scorecard published on August 26, 2025. This represents an upgrade from the company's previous Gold Medal rating. The Platinum Rating places Acutaas among the top 1% of companies assessed by EcoVadis globally for sustainability performance.
Acutaas Designates Abhishek Patel as Senior Management Person, Adjusts ESOS 2023 for Stock SplitJul 30, 2025
Jul 30, 2025Acutaas Chemicals Limited's Nomination and Remuneration Committee designated Mr. Abhishek Haribhai Patel, Vice President - Strategy, as a Senior Management Person effective July 30, 2025. Patel has been with the company since January 8, 2024, and previously served as Chief Financial Officer from 2018-2022, playing a key role in the company's 2021 IPO. He holds a Bachelor's degree in Engineering from Sardar Patel University and an MBA from ICFAI University. The committee also approved adjustments to the Employee Stock Option Scheme 2023 following a 1:2 stock split with record date April 25, 2025. Under Category I, 1,100 options granted on August 12, 2024 were adjusted to 2,200 options with exercise price reduced from Rs. 100 to Rs. 50 per option. Category II ungranted options increased from 3,34,370 to 6,68,740 options, with exercise price range adjusted from Rs. 10-610 per share to Rs. 5-305 per share. The adjustments maintain unchanged overall employee benefit values and do not require shareholder approval.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,586.70 | #1 3,80,702.50 | 33.18 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 51.86 | |
5,689.50 | 1,51,038.30 | 65.50 | 9,712.00 | 18.67 | 2,191 | 26.74 | 36.39 | |
1,499.40 | 1,21,107.70 | 22.45 | 28,409.50 | 7.12 | 5,291 | 9.88 | 38.89 | |
3,561.00 | 1,20,520.40 | 59.72 | 11,539.40 | 6.99 | 1,911 | 19.91 | 42.61 | |
1,253.10 | 1,04,580.10 | #1 18.40 | 33,741.20 | 16.73 | 5,725 | 1.26 | 46.51 | |
2,482.90 | 1,02,476.40 | 54.18 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 44.66 | |
975.00 | 98,107.80 | 21.07 | 23,511.00 | 18.55 | 4,615 | 2.60 | 50.50 | |
1,919.80 | 87,676.40 | 23.72 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.16 | |
5,433.00 | 64,959.70 | 28.53 | 13,458.30 | 3.70 | 2,216 | 21.39 | 61.31 | |
1,090.00 | 63,307.40 | 18.84 | 32,345.60 | 9.43 | 3,484 | -10.24 | 53.78 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
41.21 %
Net Income Growth
229.36 %
Cash Flow Change
-5.46 %
ROE
70.41 %
ROCE
52.45 %
EBITDA Margin (Avg.)
29.64 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 213 | 232 | 413 | 659 | 767 | 1,096 | 1,549 |
| Fixed Assets | 79 | 85 | 186 | 205 | 259 | 427 | 570 |
| Current Assets | 124 | 121 | 216 | 430 | 457 | 496 | 792 |
| Capital Work in Progress | 2 | 12 | 0 | 3 | 30 | 125 | 130 |
| Investments | 2 | 2 | 1 | 2 | 2 | 0 | 0 |
| Other Assets | 131 | 133 | 225 | 450 | 477 | 543 | 848 |
| Total Liabilities | 213 | 232 | 413 | 659 | 767 | 1,096 | 1,549 |
| Current Liabilities | 106 | 95 | 166 | 129 | 163 | 285 | 202 |
| Non Current Liabilities | 25 | 26 | 80 | 7 | 10 | 128 | 27 |
| Total Equity | 82 | 112 | 167 | 522 | 594 | 683 | 1,320 |
| Reserve & Surplus | 72 | 101 | 135 | 486 | 558 | 637 | 1,269 |
| Share Capital | 11 | 11 | 32 | 36 | 36 | 37 | 41 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 3 | -2 | -0 | 3 | -1 | 8 | 20 | -1 | 156 |
| Investing Activities | -14 | -19 | -25 | -21 | -24 | -101 | -121 | -33 | -365 | -224 |
| Operating Activities | 10 | 29 | 9 | 15 | 27 | 28 | -12 | 66 | 125 | 118 |
| Financing Activities | 4 | -7 | 15 | 6 | 0 | 72 | 140 | -12 | 239 | 261 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | May 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 49.71 % | 41.05 % | 41.05 % | 41.05 % | 41.05 % | 39.41 % | 39.41 % | 39.41 % | 39.41 % | 38.93 % | 39.91 % | 39.91 % | 39.07 % | 35.98 % | 35.97 % | 35.96 % | 35.96 % | 32.66 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 7.16 % | 0.00 % | 8.97 % | 10.01 % | 12.92 % | 13.87 % | 15.52 % | 16.48 % | 16.94 % |
| DIIs | 0.00 % | 4.85 % | 2.63 % | 4.44 % | 3.01 % | 3.28 % | 3.72 % | 3.63 % | 5.23 % | 5.94 % | 5.55 % | 6.81 % | 8.81 % | 14.81 % | 19.93 % | 20.24 % | 18.31 % | 22.38 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % |
| Public / Retail | 0.00 % | 42.98 % | 46.69 % | 44.74 % | 44.74 % | 38.35 % | 38.64 % | 38.96 % | 37.44 % | 36.13 % | 27.13 % | 30.01 % | 28.79 % | 26.06 % | 24.72 % | 23.56 % | 24.19 % | 23.27 % |
| Others | 50.29 % | 11.11 % | 9.62 % | 9.77 % | 11.19 % | 18.96 % | 18.23 % | 18.00 % | 17.92 % | 11.84 % | 27.41 % | 14.30 % | 13.33 % | 10.22 % | 5.51 % | 4.71 % | 5.05 % | 4.74 % |
| No of Share Holders | 0 | 28 | 1,38,182 | 97,547 | 93,922 | 87,044 | 85,563 | 78,786 | 70,352 | 72,897 | 83,344 | 95,784 | 92,721 | 90,329 | 93,394 | 95,756 | 1,14,060 | 1,19,890 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3 | 3 | 3 | 1.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.67 | 0.55 | 0.25 | 0.11 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Aug 2022 |  Dividend | ₹ 3.00 /share | 29 Jul 2022 | 469.45 | 519.43 |
| 18 Sept 2023 | Dividend | ₹ 3.00 /share | 18 Sept 2023 | 529.60 | 648.55 |
| 13 Sept 2024 | Dividend | ₹ 3.00 /share | 13 Sept 2024 | 596.08 | 730.05 |
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 692.10 | 768.08 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 736.58 | 806.00 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 988.83 | 953.60 |
| 16 Apr 2025 |  Change Of Name | NA | 16 Apr 2025 | 1,177.28 | 1,177.28 |
| 22 Feb 2025 |  Split | 5:10 | 25 Apr 2025 | 1,121.08 | 1,121.08 |
| 02 May 2025 | Quarterly Result Announcement | NA | 02 May 2025 | 1,100.75 | 1,130.50 |
| 10 May 2025 |  Extraordinary General Meeting | NA | 10 May 2025 | 1,177.28 | 1,160.05 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 1,187.60 | 1,167.70 |
| 18 Sept 2025 | Dividend | ₹ 1.50 /share | 18 Sept 2025 | 1,130.50 | 1,472.35 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 1,413.30 | 1,449.70 |
Announcements
Closure of Trading Window1 day ago
1 day agoIntimation Under Regulation 30 Of SEBI (LODR) Regulations 20152 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Allotment2 days ago
2 days agoShareholder Meeting / Postal Ballot-Scrutinizers Report2 days ago
2 days agoShareholder Meeting / Postal Ballot-Outcome of AGM2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Intimation Of Record Date For The Purpose Of Final Dividend For The FY 2024-25Sep 02, 2025
Sep 02, 2025Communication To Shareholders - Intimation On Deduction Of Tax On DividendSep 02, 2025
Sep 02, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 01, 2025
Sep 01, 2025Reg. 34 (1) Annual Report.Sep 01, 2025
Sep 01, 2025Reg. 34 (1) Annual Report.Sep 01, 2025
Sep 01, 2025Notice Of The 18Th AGM Of The Company Scheduled To Be Held On September 25 2025Sep 01, 2025
Sep 01, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 29, 2025
Aug 29, 2025Regulation 30 Update - Intimation Of Platinum Medal Accreditation/Rating By EcovadisAug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement Under Reg 30 Of SEBI (LODR) Regulations 2015Jul 30, 2025
Jul 30, 2025Recording Of Earnings Conference Call Held On July 30 2025Jul 30, 2025
Jul 30, 2025Statement Of Deviation & Variation For The Quarter Ended June 30 2025 - Preferential IssueJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025
Jul 30, 2025Unaudited Standalone And Consolidated Financial Results For First Quarter Ended June 30 2025Jul 30, 2025
Jul 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On July 30 2025Jul 30, 2025
Jul 30, 2025Intimation Of Change Of Name Of Wholly Owned Subsidiary Company From Ami Organics Electrolytes Private Limited To Acutaas Chemicals Electrolytes Private LimitedJul 28, 2025
Jul 28, 2025Intimation Of Earnings Conference Call Scheduled On Wednesday July 30 2025 At 4.30 P.M. (IST)Jul 25, 2025
Jul 25, 2025Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025 To Be Held On July 30 2025Jul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-AcquisitionJul 23, 2025
Jul 23, 2025Intimation Of Name Change Of Wholly Owned Subsidiary CompanyJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Jul 11, 2025Announcement under Regulation 30 (LODR)-Joint VentureJun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Intimation Under Reg 30 Of SEBI (LODR) Regulations 2015Jun 10, 2025
Jun 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2025
Jun 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
May 23, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 21, 2025
May 21, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change of Company NameMay 15, 2025
May 15, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 10, 2025
May 10, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMMay 10, 2025
May 10, 2025Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015May 10, 2025
May 10, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 08, 2025
May 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2025
May 03, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 03, 2025
May 03, 2025Recording Of Earnings Call Held On May 2 2025 At 2.30 P.M. (IST)May 02, 2025
May 02, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 02, 2025
May 02, 2025Statement Of Deviation & Variation For The Quarter Ended March 31 2025 For QIP Issue ProceedsMay 02, 2025
May 02, 2025Statement Of Deviation & Variation For The Quarter Ended March 31 2025 For Preferential Issue ProceedsMay 02, 2025
May 02, 2025Technical Indicators
RSI(14)
Neutral 38.51
ATR(14)
Volatile 42.97
STOCH(9,6)
Neutral 27.10
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -16.50
ADX(14)
Strong Trend 37.57
UO(9)
Bearish 37.11
ROC(12)
Downtrend And Accelerating -6.87
WillR(14)
Oversold -95.51
Mutual Fund Holdings
Motilal Oswal Focused Fund Direct-Growth 
ICICI Prudential Children's Fund Direct-Growth 
SBI Healthcare Opportunities Fund Direct Plan-Growth 
Tata India Pharma & Healthcare Fund Direct-Growth 
Bank of India ELSS Tax Saver Direct-Growth 
JM Midcap Fund Direct - Growth 
TRUSTMF Multi Cap Fund Direct-Growth 
Helios Mid Cap Fund Direct-Growth 
UTI Innovation Fund Direct - Growth 
Samco Multi Cap Fund Direct-Growth 
TRUSTMF Flexi Cap Fund Direct - Growth 
LIC MF Focused Fund Direct - Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
Bandhan Nifty Total Market Index Fund Direct-Growth 
Mirae Asset Nifty Total Market Index Fund Direct-Growth 
Quant Multi Cap Fund Direct-Growth 
ITI Small Cap Fund Direct-Growth 
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
